Sunflower Pharmaceutical GroupLtd Balance Sheet Health
Financial Health criteria checks 6/6
Sunflower Pharmaceutical GroupLtd has a total shareholder equity of CN¥4.7B and total debt of CN¥609.7K, which brings its debt-to-equity ratio to 0.01%. Its total assets and total liabilities are CN¥5.9B and CN¥1.2B respectively. Sunflower Pharmaceutical GroupLtd's EBIT is CN¥891.3M making its interest coverage ratio -13.8. It has cash and short-term investments of CN¥2.2B.
Key information
0.01%
Debt to equity ratio
CN¥609.65k
Debt
| Interest coverage ratio | -13.8x |
| Cash | CN¥2.20b |
| Equity | CN¥4.70b |
| Total liabilities | CN¥1.23b |
| Total assets | CN¥5.93b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 002737's short term assets (CN¥3.9B) exceed its short term liabilities (CN¥980.7M).
Long Term Liabilities: 002737's short term assets (CN¥3.9B) exceed its long term liabilities (CN¥252.7M).
Debt to Equity History and Analysis
Debt Level: 002737 has more cash than its total debt.
Reducing Debt: 002737's debt to equity ratio has reduced from 13.4% to 0.01% over the past 5 years.
Debt Coverage: 002737's debt is well covered by operating cash flow (16894%).
Interest Coverage: 002737 earns more interest than it pays, so coverage of interest payments is not a concern.